President, Consumer · GoodRx Holdings, Inc. (GDRX)

Andrew Slutsky

A named executive officer of GoodRx in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$864,801

Salary $500,000Stock awards $0Bonus $378

FY2020: $48,936,515

4th of 6 named executive officers at GoodRx by FY2021 total.

6 named officers on file for GoodRx, FY2021

Andrew Slutsky’s pay file — $29

  • 3 fiscal years of pay, line by line
  • GDRX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GoodRx’s whole pay program stands against its peers

  • GoodRx’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GDRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2022 (DEF 14A).

Free

Get Andrew Slutsky’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Andrew Slutsky compensation by year

GoodRx Summary Compensation Table · all 3 fiscal years held
In US dollars, as GoodRx reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$324,000$425,000$500,000
Bonus$0$971$378
Stock awards$0$48,389,999$0
Option awards$0$0$0
Non-equity incentive$118,357$115,200$357,176
Pension and deferred compensation$0$0$0
All other$8,920$5,345$7,247
Total$451,277$48,936,515$864,801

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GoodRx Holdings, Inc. DEF 14A filed April 27, 2022, accession 0001193125-22-123943, and prior-year filings.

How this page was built: the GoodRx Holdings, Inc. filed document, accession 0001193125-22-123943. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2022.

$451K
$48.9M
$865K
FY19
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU750,000$24,510,000—

Per the Outstanding Equity Awards at Fiscal Year-End table in GoodRx Holdings, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Change-in-control & termination

estimated payments GoodRx discloses, by trigger · FY2021
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Disability$500,000$0$24,197$524,197
Involuntary termination without cause$500,000$0$24,197$524,197
Change in control and resignation for good reason$500,000$0$24,197$524,197
Death$500,000$0$24,197$524,197
Resignation for good reason, no change in control$500,000$0$24,197$524,197
Change in control and involuntary termination$500,000$0$24,197$524,197

Per the Potential Payments Upon Termination or Change in Control table in GoodRx Holdings, Inc.'s FY2021 proxy. Estimates as the company printed them; a dash means it printed no figure.

GoodRx’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Trevor BezdekCo-Chief Executive Officer$891,681
Douglas HirschCo-Chief Executive Officer$879,104
Bansi NagjiPresident, Healthcare$866,965
Andrew Slutsky · this pagePresident, Consumer$864,801
Karsten VoermannChief Financial Officer$520,970
Babak AzadChief Marketing Officer$500,397

The full GoodRx compensation record

free company brief

This page is one person within GoodRx's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GoodRx proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GoodRx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Andrew Slutsky's compensation dossier · One-time report. No refunds.